Related Experiment Videos

Hypercalciuria in chronically institutionalized bedridden children: frequency, predictive factors and response to

The International Journal of Pediatric Nephrology
|January 1, 1987
PubMed

Insights

Hypercalciuria (high urinary calcium) is common in bedridden children with neurologic disorders, increasing fracture risk. Treatment with thiazides effectively reduced urinary calcium levels.

Area of Science:

  • Pediatric Nephrology
  • Pediatric Endocrinology
  • Bone Metabolism

Background:

  • Chronic immobilization in children with neurologic disorders is associated with potential metabolic complications.
  • Hypercalciuria, elevated urinary calcium excretion, is a recognized concern in various pediatric populations.

Purpose of the Study:

  • To investigate the prevalence of hypercalciuria in chronically institutionalized, bedridden children with neurologic disorders.
  • To explore the association between hypercalciuria and bone health, specifically limb fractures.
  • To evaluate the efficacy of hydrochlorothiazide-amiloride treatment in reducing urinary calcium excretion.

Main Methods:

  • Analysis of urine calcium and creatinine ratios (UCa/UCr) in 42 institutionalized children (ages 2-16).
  • Comparison of hypercalciuric and normocalciuric groups regarding clinical and demographic factors.
  • Assessment of limb fracture incidence in both groups over three years.
  • Intervention with hydrochlorothiazide-amiloride for three weeks in hypercalciuric children.

Main Results:

  • Hypercalciuria (UCa/UCr > 0.21) was identified in 42.8% of the children.
  • Hypercalciuric children experienced a significantly higher incidence of limb fractures (p < 0.02).
  • Treatment with hydrochlorothiazide-amiloride reduced mean UCa/UCr by 57.7% (p < 0.005), with only four children remaining hypercalciuric.

Conclusions:

  • Resorptive hypercalciuria is prevalent in chronically immobilized, bedridden children with neurologic disorders.
  • Screening for hypercalciuria is crucial due to its link with impaired bone metabolism and increased fracture risk.
  • Thiazide-based therapy is an effective strategy for managing hypercalciuria and potentially reducing morbidity in this vulnerable pediatric population.

Related Concept Videos